MENU
EDSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Edesa Biotech (EDSA) Ownership - Who owns Edesa Biotech?
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more
Profile
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.03M
P/E Ratio
N/A
Total Cash
12.36M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash/Share
1.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
EDSA
Capitalization
17M
P/E Ratio
N/A
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash
12.4M
Total Cash/Share
1.76
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.91M
P/B Ratio
3.47
Cash Flow
N/A
Earnings
-1.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54.3M
Current Ratio
18.97
Current Revenue Per Employee
41.67
Dividends Per Share - Security
N/A
EBITDA
-5.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
-362.80
Revenue To Assets
-59.10
Shares Held By Institutions
6.94M
Shares Outstanding - Current
7.04M
Total Liabilities
673K
Total Volume MTD
N/A
Value
-1
Gain YTD
44.048
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com